Glaucoma Surgery Companies

Alcon Acquires Ivantis, Developer of the Novel Hydrus Microstent January 2024 acquisition strengthens Alcon's position in the minimally invasive glaucoma surgery (MIGS) market and expands their portfolio of devices for open-angle glaucoma patients. The Hydrus Microstent is a tiny implant that helps drain excess fluid from the eye and reduce intraocular pressure.

Johnson & Johnson Vision Partners with Glaukos Corporation for iStent® inject Trabecular Micro-Bypass System strategic partnership announced in December 2023 leverages the combined expertise of both companies to bring the iStent inject system to a wider range of surgeons and patients worldwide. The iStent inject is a MIGS device designed to create a bypass channel in the trabecular meshwork, the eye's natural drainage system.

Glaukos Announces First Patient Enrolment in Phase II Clinical Trial for GLK-301 January 2024 development marks a significant step forward for Glaukos in their pipeline of new treatments for glaucoma. GLK-301 is a novel sustained-release drug implant designed to lower intraocular pressure and potentially offer a longer-lasting alternative to traditional eye drops.

Iridex Launches New Iridex 532 and Iridex 577 Lasers for Retina and Glaucoma January 2023 launch introduces next-generation lasers with advanced features for both retina and glaucoma procedures. These lasers offer improved precision and versatility, potentially leading to better outcomes for patients.

List of Glaucoma Surgery Key Companies in the Market

• Abbott Laboratories Inc


• Carl Zeiss Meditec.


• Ziemer Ophthalmic Systems


• ASICO, LLC.


• Lumenis


• Allergan


• Alcon


• Katalyst Surgical LLC


• Glaukos Corporation